Search results for

In 2016, for better or worse, LatAm's equity market activity will largely hinge on the stability of local currencies. And counsel are cautiously optimistic. The region is not known for a robust equity market, but according to Shearman & Sterling partner Antonia Stolper, last year was in a class of its own. "2015 was truly bad," she says. "We had the whole Fibra boom in Mexico in the last two years and other one offs in some other countries. But the pipeline is somewhat weak."

Maria Pía Talavera Barclay A merger is a corporate reorganisation that involves the combining of different companies into a single company in order to enhance the financial and operational strengths of the corresponding organisations. Peruvian law provides that by virtue of a merger, one or more companies transfer in a single act all of their assets (property, rights, obligations and/or liabilities) in favour of a new or existing company, which absorbs them in their entirety, causing in turn the dissolution of the companies transferring their assets. Due to the relevance of the legal implications of a merger (among other things, the transfer of all of the assets of a company), it is pivotal to have certainty on the effective date of such corporate reorganisation. Unfortunately, Peruvian corporate laws are not clear in this respect.

Masanori Tosu On November 25 2014, an amendment to the Pharmaceuticals and Medical Devices Law (the Law) came into effect and introduced important changes to Japan's medical products regulatory regime, including the establishment of regulations for regenerative medical products (for example, regenerative medicines using iPS cells). Indeed, since the Minister of Health, Labour and Welfare issued the first marketing authorisations for two regenerative medical products on September 18 2015, the medical products business in Japan and its regulation have received a good deal of attention.

This latest instalment of Corporate Governance Quarterly looks at how US courts seem to be shifting to advisors responsibility for directors’ failure to fulfill their duty of care

A proposed rulebook shares similarities with the US framework. Will it create tension with broader moves to liberalise investment?

The total loss-absorbing capacity metric has now been finalised. Its subordination exception has important ramifications for many European G-Sibs

When entering in to swaps with an international organisation, what do you need to think about to sleep easy? Hogan Lovells’ James Doyle and Oliver West have the answers

This year’s crash has forced the government to address the cracks in its financial regulatory system. These legal and policy considerations will shape a new regime

Shearman & Sterling’s Barney Reynolds, Danforth Newcomb and James Campbell discuss aspects of the nuclear deal that create real risks for foreign investors

Rulemakers in the region want a common regulatory infrastructure rather than simply importing Western regimes